CurrentBlue Cross Blue Shield - OklahomaPolicy CPCPLAB050

Urine Culture Testing for Bacteria

Reimbursement and coding criteria for urine culture testing (including isolate identification and antibiotic susceptibilities) for Blue Cross Blue Shield of Oklahoma products; specifies when testing is reimbursable or not and who is affected (providers submitting claims and covered members).

Policy Summary

PayerBlue Cross Blue Shield - Oklahoma

PolicyUrine Culture Testing for Bacteria

Policy CodePolicy CPCPLAB050

Change TypeNon‑material updates (terminology and literature review)

Effective DateJan 15, 2025

Next Review DateN/A

Key ActionSubmit accurate documentation for urine culture testing claims and provide additional documentation upon request; claims are subject to plan coverage and coding review.

SourceLink

POLICY UPDATE CHANGES

Document updated with literature review; Reimbursement Information unchanged.

Reimbursement Information revised for clarity and language changed to use 'individuals' instead of 'women' or 'patients'.

New policy created on 11/01/2022.

2025-01-15Plan Effective Date

10/30/2024Approval / last review date

7Distinct guidance bullets

CPCPLAB050Policy identifier

Policy Summary

PayerBlue Cross Blue Shield - Oklahoma

PolicyUrine Culture Testing for Bacteria

Policy CodePolicy CPCPLAB050

Change TypeNon‑material updates (terminology and literature review)

Effective DateJan 15, 2025

Next Review DateN/A

Key ActionSubmit accurate documentation for urine culture testing claims and provide additional documentation upon request; claims are subject to plan coverage and coding review.

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Reimbursement criteria for urine culture testing

Urine culture testing with isolate identification and antibiotic susceptibilities may be reimbursable when the following criteria are met:

ANY of the following

ALL of the following
- Pregnant individuals: urine culture testing may be reimbursable.
ALL of the following
- Asymptomatic individuals undergoing urological interventions that breach the mucosa: urine culture testing may be reimbursable prior to the procedure.
ALL of the following
- Individuals exhibiting at least one sign or symptom of possible UTI or bacteriuria: urine culture testing may be reimbursable.
ALL of the following
- Assessment of pyelonephritis: urine culture testing may be reimbursable.

ALL of the following

All other instances of asymptomatic urinary tract infection or asymptomatic bacteriuria not described above: urine culture testing is not reimbursable.

Not reimbursable (specific exclusions)

Follow-up urine culture testing for an uncomplicated urinary tract infection when there is evidence of clinical resolution: not reimbursable.
As part of initial screening for asymptomatic prostatitis: not reimbursable.
As part of assessment or prognosis of prostate biopsy: not reimbursable.

Coding and Billing Guidance

Code guidance (general)mixed

Policy states the following is not an all-encompassing code list; inclusion does not guarantee coverage.

Coding standards

Coding guidanceClaims should be coded according to industry standard coding guidelines, including but not limited to: Uniform Billing Editor; American Medical Association Current Procedural Terminology (CPT); CPT Assistant; Healthcare Common Procedure Coding System (HCPCS); ICD-10-CM and PCS; National Drug Codes (NDC); Diagnosis Related Group (DRG) guidelines; Centers for Medicare and Medicaid Services (CMS) National Correct Coding Initiative (NCCI) policy manual and CCI table edits.

Use of valid code setsProviders are expected to submit claims using valid code combinations from HIPAA-approved code sets.

Claim review and editsClaims are subject to code edit protocols, coding software logic, and claim review including plan benefit terms, provider contract language, medical policies, and clinical payment and coding policies.

Documentation requirementProviders are responsible for submission of accurate documentation and may be asked to submit additional documentation upon request.

Conflict precedenceIf conflicts exist, applicable plan documents or provider contracts govern over this policy as specified in plan/provider agreements.

Provider Responsibilities & Claim Review

Documentation Required

Documentation & Claim Review — Providers must submit accurate documentation and may be asked to provide additional documentation; claims subject to plan review

Providers are responsible for submission of accurate documentation of services performed. Providers are expected to submit claims for services rendered using valid code combinations from HIPAA-approved code sets and to code appropriately per industry standard coding guidelines (e.g., Uniform Billing Editor, AMA CPT, HCPCS, ICD-10-CM/PCS, NDCs, DRG rules, CMS NCCI edits). Claims are subject to code edit protocols and claim review against benefit coverage, provider contract language, medical policies, clinical payment and coding policies, and coding software logic. Upon request, providers must submit additional documentation to support medical necessity and coding.

Submit accurate, complete documentation when requested
Use valid HIPAA-approved codes and follow standard coding guidelines
Claims are subject to plan and policy review and code-edit protocols

Denial Risk

Prior authorization / coverage risk — prior auth not specified; reimbursement limited to listed clinical indications and may be denied outside them

Prior authorization is not specified in this policy; however, reimbursement is limited to the clinical indications listed in the policy and may be denied when services fall outside those indications or when documentation does not support medical necessity. Providers should verify member benefits and any plan-specific prior authorization requirements before rendering services. Claims for services not meeting the listed clinical indications or lacking supporting documentation may be denied or subject to retrospective review.

Reimbursement limited to listed clinical indications — services outside those indications may be denied
Verify member benefits and any plan-specific prior authorization requirements prior to service
Claims lacking documentation of medical necessity may be denied or audited retrospectively

Signs, Symptoms & Definitions

Signs and symptoms of UTI/bacteriuria

FeverFever is listed as a sign/symptom of UTI/bacteriuria.

Urinary urgency/frequency/dysuriaUrgency to urinate; feeling the need to urinate despite an empty bladder; increased frequency of urination; and dysuria are included.

Pelvic, suprapubic, flank pain and urinary changesSuprapubic tenderness, pelvic pressure, lower back and side (flank) pain, change in urine smell, cloudy urine, hematuria, and pyuria are included.

Systemic symptomsNausea, vomiting, chills, and night sweats are included.

Laboratory findingAbnormal urinalysis findings are considered a sign/symptom of UTI/bacteriuria.

OpenPayer

Urine Culture Testing for Bacteria

Reimbursement Criteria

Coding and Billing Guidance

Provider Responsibilities & Claim Review

Signs, Symptoms & Definitions